ClinicalTrials.gg
CompletedNCT04208633Updated Dec 23, 2019

Correlation Between Sulcus Anatomy and Other Parameters After Horizontal & Vertical Intraocular Lens (IOLs) Placements

An interventional study of Horizontal placement of the intraocular lens in the capsular bag and Vertical placement of the intraocular lens in the capsular bag in Cataract and Pseudophakia, sponsored by Brighton and Sussex University Hospitals NHS Trust. Completed at 1 site in United Kingdom. Open to participants aged 18 Years to 95 Years. Per ClinicalTrials.gov, last updated 2019-12-23.

Sponsored by Brighton and Sussex University Hospitals NHS Trust · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 3 years 3 months after the study started (first participant enrolled Sep 2016, registered Dec 2019).
Phase
Not applicable
Study type
Interventional
Enrollment
46
Allocation
Randomized
Ages
18 Years to 95 Years
Sex
All
01

Study summary

Usually following cataract surgery patients would expect to have normal distance vision and not require the use of distance glasses. However, in clinical practice desired vision post cataract surgery is not achieved sometimes. In such cases a piggyback lens is used to enhance the visual outcome. This lens is placed in the ciliary sulcus (space between the iris and the lens). Often this piggyback lens is not the best fit for the ciliary sulcus space and it moves. This study will be using ultrasound biomicroscopy to measure the ciliary sulcus dimensions pre and postoperatively to estimate the normal anatomy and it's variations. Patients in this study will be randomised as to which way the intraocular lens is placed in the eye (horizontally or vertically) at the time of their cataract surgery. Patients requiring cataract surgery in both eyes will be identified from the Eye Hospital at the Royal Sussex County Hospital. Patients will be in the study for up to 6 months from being identified as suitable through to the operation in the 2nd eye and a final study visit.

Read the detailed description

Study Design This is a prospective, fellow eye randomised study.

Recruitment

A sample size of 92 eyes (46 patients) was calculated. Patients will be recruited at the Sussex Eye Hospital preoperative cataract assessment clinics where they will be screened and given a patient information sheet by a member of the research team if they can be recruited. They will be allowed to take this home to discuss with their family/friends and/or GP. They will be asked if the research team could contact them in a weeks time to discuss the study and the plan for the day of their surgery (which is their next NHS visit). Patients can then agree or decline to participate in the study . If they decline, their normal NHS pathway will continue. If they accept, written informed consent will be taken on the day of surgery as well as any extra imaging required. The key points of the trial will be reiterated and the patient will be invited to ask any questions. All members of the research team are NIHR GCP trained. All research patients will undergo surgery by the same surgeon and attend for post-operative follow-up at the Sussex Eye Hospital. In addition at this visit a research appointment will be made to undertake the research scans and examinations (see details below) by an experienced member of our research team. The research team including the surgeon cannot be blinded as the obvious direction of placement of the intraocular lens will be visible during surgery and during examination.

Pre-operative appointment

Consent If the patient would like to participate they will be asked to read and sign a consent form. If the patient gives consent for their GP to be notified of their participation in the study a letter will be sent to the GP.

Standard pre-operative protocol for all NHS patients:

  1. Unaided and best corrected distance visual acuity
  2. Intraocular pressure measurement (applanation tonometry)
  3. Optical or ultrasound biometry for lens power calculation
  4. Slit lamp examination of the eye (by a doctor) including dilated fundus evaluation For non-standard (research) measurements, patients will be asked to return for a separate appointment. All measurements will be performed at ambient room light (undilated pupil).

The assessment will continue as follows:

  1. Scheimpflug scans (Pentacam)
  2. Anaesthesia of the eye with proxymetacaine 1%
  3. Measurement using digital calipers of the white-to-white diameter Carbomer gel will be applied to protect the cornea before application of ultrasound probe
  4. Contact ultrasound biomicroscopy images will be taken in 4 axes: vertical, horizontal, temporal oblique and nasal oblique. The patient will be asked to fixate with the fellow eye on a target to maintain fixation and avoid accommodation. The examination will be performed with undilated pupils.

Surgery

All surgery will be carried out by the same surgeon (Principal Investigator) who is an experienced senior Ophthalmic Surgeon. This is to avoid any surgery-induced study biases. Surgery will be performed employing a standardized technique with aspheric monofocal intraocular lenses. The eyes will be randomized (1:1) using a dedicated computer programme prior to the start of the study to have a vertical or horizontal placement of the intraocular lens in the capsular bag. The 0 and 180 degrees will be marked on the slit lamp prior to the surgery. The axes of the IOL will be orientated in reference to the midpoint of the optic haptic junction of the IOL.

Non-standard (research)intervention post-operatively on the day of surgery:

Image taken with anterior segment ocular coherence tomography.

Standard post-operative protocol for all NHS patients at 4-6 weeks:

  1. Unaided and best corrected distance visual acuity 2) Intraocular pressure measurement (applanation tonometry) 3) Slit lamp examination of the eye Non-standard (research) post-operative measurements for patients enrolled in this study (performed at the time convenient to patient and the research team): All measurements will be performed at ambient room light (undilated pupil).
  1. Dilated retroillumination images of the IOL immediately postoperatively (ideally on the day of the surgery)
  2. Scheimpflug scans (Pentacam®) at 4-6 weeks
  3. Anaesthesia of the eye with proxymetacaine 1% at 4-6 weeks
  4. Carbomer gel will be applied to protect the cornea before application of ultrasound probe. The patient will be asked to fixate with the fellow eye on a target to maintain fixation and avoid accommodation. This examination performed with undilated pupils at 4-6 weeks.
  5. Contact ultrasound biomicroscopy images at 4-6 weeks will be taken in 4 axes: vertical, horizontal, temporal oblique and nasal oblique.
02

Conditions studied

  • Cataract
  • Pseudophakia

Keywords

  • cataract
  • pseudophakia
  • intraocular lens
  • ciliary sulcus
  • anatomy
03

In context

Cataract

1,629 studies on the registry are indexed under Cataract; 235 are open to participants now.

This study's enrollment of 46 is below the median of 79 across 1,092 interventional studies indexed under Cataract.

Browse Cataract studies →

Lead sponsor

Brighton and Sussex University Hospitals NHS Trust is the lead sponsor of 22 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 95 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with cataracts undergoing cataract extraction in both eye.
  • Diopters of corneal astigmatism Scheimpflug imaging (Pentacam HR, Oculus, Germany)

Exclusion criteria

Exclusion Criteria:

  • Less than 18 years
  • Significant ophthalmic co-morbidity that may affect the anatomy of the eye
  • Not competent to give fully
  • Unable to have surgery and attend follow up appointment at Sussex Eye Hospital, Brighton
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
46 participants (actual)

Study arms

  • Other
    Horizontal placement of the intraocular lens

    The eyes randomised to have horizontal placement of intraocular lenses

    Procedure: Horizontal placement of the intraocular lens in the capsular bag

  • Other
    Vertical placement of the intraocular lens

    Fellow eye receiving vertical placement of intraocular lens.

    Procedure: Vertical placement of the intraocular lens in the capsular bag

Interventions

  • ProcedureHorizontal placement of the intraocular lens in the capsular bag

    The eyes will be randomized (1:1) using a dedicated computer programme prior to the start of the study to have a vertical or horizontal placement of the intraocular lens in the capsular bag. The 0 and 180 degrees will be marked on the slit lamp prior to the surgery. The axes of the IOL will be orientated in reference to the midpoint of the optic haptic junction of the IOL. the fellow eye will receive the opposite placement (horizontal or vertical) of the IOL.

  • ProcedureVertical placement of the intraocular lens in the capsular bag

    The eyes will be randomized (1:1) using a dedicated computer programme prior to the start of the study to have a vertical or horizontal placement of the intraocular lens in the capsular bag. The 0 and 180 degrees will be marked on the slit lamp prior to the surgery. The axes of the IOL will be orientated in reference to the midpoint of the optic haptic junction of the IOL. the fellow eye will receive the opposite placement (horizontal or vertical) of the IOL.

06

What researchers measure

Primary outcomes

  1. Sulcus diameter versus anterior chamber dimension

    Correlations between sulcus diameter and anterior chamber dimensions in the 4 axes pre and post operatively and also for the differences post and pre operatively.

    Time frame: 1 month

Secondary outcomes

  1. Changes in sulcus diameter in 4 axes in eyes with vertical and horizontal placement of IOLs

    Measured on UBM

    Time frame: 1 month

  2. Changes in anterior chamber depth following cataract extraction

    Measured on UBM and Pentacam

    Time frame: 1 month

  3. Changes in anterior chamber diameter following cataract extraction

    Measured on UBM and Pentacam

    Time frame: 1 month

  4. Rotation of the IOL in degrees from it's primary placement at 4-6 weeks at postoperative follow up.

    Measured on retro-illumination photographs

    Time frame: 1 month

  5. To explore any relationship between demographics in relation to sulcus anatomy

    Analysed from the demographics

    Time frame: 1 month

07

Study locations

1 site
  • Brighton & Sussex University Hospitals NHS Trust
    Brighton, Sussex BN2 5BF, United Kingdom
08

References and documents

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Sep 2016 to primary completion in Jan 2019, 27 months.

Of 300 non-industry interventional studies with no phase under Cataract, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 30. This study's 27 months is above that.

Counting every sponsor, half of 490 studies reached it within 17 months; a quarter within 9 and three quarters within 28.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 17, 2019
First posted
Dec 23, 2019
StartActual
Sep 14, 2016
Primary completionActual
Jan 5, 2019
CompletionActual
Jan 5, 2019
Last update
Dec 23, 2019
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 23, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04208633
Lead sponsor
Brighton and Sussex University Hospitals NHS Trust
Responsible party
Sponsor
First posted
Dec 23, 2019
Start date
Sep 14, 2016
Primary completion
Jan 5, 2019
Completion
Jan 5, 2019
Last update
Dec 23, 2019

Study contacts

Mayank Nanavaty
study chair · Brighton and Sussex University Hospitals NHS Trust

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion